[Cancer as a specific variant of the evolutionary resistance of adapted cells to damaging factors].
Monceviciūte-Eringiene
E
E
D000222:Adaptation, Physiological / Q000187:drug effects; D000818:Animals; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors; D018407:Bacterial Physiological Phenomena; D005075:Biological Evolution; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000502:physiology; D007740:L Forms / Q000502:physiology; D009369:Neoplasms / Q000276:immunology / Q000503:physiopathology*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000503:physiopathology*
D000970:Antineoplastic Agents; D002273:Carcinogens